Skip to main content

Dyne Therapeutics, Inc.

DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001818794

In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Dyne Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of DYN: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders2004200+4
Shares112.4M198.2K111.6M−594.9K (−0.5%)
Value$4.03B$7.12M$2.63B−$1.40B (−34.7%)

4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (38)

Institutions that held Dyne Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to DYN in Q4 2024
InstitutionSharesValue% of portfolio
Jefferies Financial Group Inc.1,800,000$42.4M0.47%
Braidwell LP681,182$16.0M0.48%
Frontier Capital Management Co LLC298,052$7.02M0.07%
Integral Health Asset Management, LLC150,000$3.53M0.31%
Springhill Fund Asset Management (HK) Co Ltd131,200$3.09M5.02%
Cubist Systematic Strategies, LLC119,065$2.81M0.05%
Voloridge Investment Management, LLC119,015$2.80M0.01%
Raymond James Financial Inc99,328$2.34M0.00%
Superstring Capital Management LP73,150$1.72M1.51%
BNP Paribas Arbitrage, SA66,998$1.58M0.00%
Darwin Advisors, LLC52,090$1.23M0.41%
Jump Financial, LLC50,911$1.20M0.03%
Hudson Bay Capital Management LP35,000$824.6K0.00%
Brevan Howard Capital Management LP28,781$678.1K0.02%
Skandinaviska Enskilda Banken AB (publ)26,816$634.2K0.00%
Standard Life Aberdeen plc25,803$607.9K0.00%
Marshall Wace, LLP24,501$577.2K0.00%
Verition Fund Management LLC22,702$534.9K0.00%
Police & Firemen's Retirement System of New Jersey17,179$404.7K0.00%
Syon Capital LLC16,930$398.9K0.04%
HRT Financial LP16,722$393.0K0.00%
Legato Capital Management LLC12,960$305.3K0.04%
Magnetar Financial LLC11,181$263.4K0.01%
KLP Kapitalforvaltning AS10,900$256.8K0.00%
Neo Ivy Capital Management8,715$205.0K0.04%
GF Fund Management Co. Ltd.2,137$50.3K0.00%
Caitong International Asset Management Co., Ltd646$15.2K0.01%
Group One Trading, L.P.613$14.4K0.00%
R Squared Ltd440$10.4K0.01%
Spire Wealth Management300$7.07K0.00%
Venturi Wealth Management, LLC270$6.36K0.00%
Amundi21$4840.00%
SBI Securities Co., Ltd.19$4480.00%
Aster Capital Management (DIFC) Ltd18$4240.00%
CoreCap Advisors, LLC7$1650.00%
IFP Advisors, Inc3$710.00%
EverSource Wealth Advisors, LLC3$710.00%
Global Retirement Partners, LLC3$710.00%

Sold out (34)

Institutions that held Dyne Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (4)

Institutions that held Dyne Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DYN in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Ghost Tree Capital, LLC100,000$3.59M
Raymond James & Associates49,027$1.76M
Raymond James Financial Services Advisors, Inc.38,782$1.39M
PEAK6 Investments LLC10,400$373.6K